The Ah receptor (AHR) is directly involved in the regulation of both innate and adaptive immunity. However, these activities are poorly understood at the level of gene regulation. The chemokine (c-c motif) ligand 20 (CCL20) plays a nonredundant role in the chemoattraction of C-C motif receptor 6 expressing cells (eg, T cells and others). A survey of promoter regions of chemokine genes revealed that there are several putative dioxin responsive elements in the mouse Ccl20 promoter. The addition of an AHR agonist along with lipopolysaccharide (LPS) to cultured primary peritoneal macrophages results in synergistic induction of both Ccl20 mRNA and protein, compared with each compound alone. Through the use of macrophage cultures derived from Ahr À/À and Ahr nls/nls mice, it was established that expression of the AHR and its ability to translocate into the nucleus are necessary for AHR ligand-mediated synergistic induction of Ccl20. Gel shift analysis determined that a potent tandem AHR binding site $3.1 kb upstream from the transcriptional start site can efficiently bind the AHR/ARNT (aryl hydrocarbon receptor/AHR nuclear translocator) heterodimer upon activation with a number of AHR agonists. Furthermore, studies reveal that LPS increases AHR levels on the Ccl20 promoter while decreasing HDAC1 occupancy. The level of Ccl20 constitutive expression in the colon is greatly attenuated in Ahr À/À mice.
Chemokines are a diverse superfamily of low molecular weight chemotactic cytokines, which mediate leukocyte migration and hence play crucial roles in immune homeostasis and inflammation (Murdoch and Finn, 2000) . The innate immune system provides the first line of defense to pathogens, primarily via recognition of foreign molecules through pattern recognition receptors (Kawai and Akira, 2010) . Such signaling drives the production of a distinct set of chemokines and cytokines that dictate the specificity of the adaptive immune response (Luster, 2002) . Chemokines are classified by a number of criteria, including their arrangement of conserved cysteine residues in the Nterminus. Four configurations stratify this superfamily into the C, C-C, CXC, and CX3C subfamilies (Murdoch and Finn, 2000; Zlotnik and Yoshie, 2000) . Chemokines can also be functionally classified as homeostatic versus inflammatory (Comerford and McColl, 2011) . Inflammatory chemokines are expressed at low levels basally, but are induced at the mRNA level by proinflammatory cytokines and pathogen-derived insults (Ye and Young, 1997) . Chemokines mediate directed chemotaxis by binding and signaling through transmembrane G protein-coupled receptors.
The chemokine (c-c motif) ligand 20 (CCL20) is a member of the C-C family of chemokines that bind a single cognate receptor, C-C motif receptor 6 (CCR6), expressed on the surface of immature dendritic cells, B cells, T H 17 cells, and Treg cells (Le Borgne et al., 2006; Schutyser et al., 2003; Yamazaki et al., 2008) . Basal Ccl20 expression varies across tissue types, but can be markedly induced by inflammatory cytokine challenge or pathogen-derived insults such as LPS (Hosokawa et al., 2005; Schutyser et al., 2000; Sierro et al., 2001) . As with many chemokines, inducible expression is regulated at the transcriptional level by NF-kB and AP-1 transcription factors (Kanda et al., 2009) . Its pleiotropic nature has made the delineation of the cellspecific recruitment difficult to determine; however, it is likely that effector cell types recruited by Ccl20 is highly context dependent (Comerford et al., 2010) . CCL20 has been implicated in a multitude of human pathologies, including cancer of a variety of tissues, atherosclerosis, psoriasis, rheumatoid arthritis, and multiple sclerosis (Harper et al., 2009; Hirota et al., 2007; Lahoti et al., 2013; Rubie et al., 2010) . As such, a detailed understanding of mechanisms underlying Ccl20 expression is warranted.
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor and member of the basic helix-loop-helix, Per-Arnt-Sim family of proteins. Historically, AHR has been studied as a mediator of polycyclic aromatic hydrocarbon metabolism and resulting carcinogenesis. In addition, the toxicities associated with dioxin are almost completely mediated by the AHR (Bunger et al., 2003) . Prior to ligand activation, AHR resides in the cytoplasm complexed with a number of chaperones and cochaperones, including the 90 kDa heat shock protein (HSP90) (Petrulis and Perdew, 2002) . Upon agonist binding the AHR translocates to the nucleus, disassociates from HSP90 and heterodimerizes with its binding partner, AHR nuclear translocator (ARNT). This heterodimeric complex is capable of binding to dioxin-response elements (DREs) and transactivating a number of genes involved in a wide variety of functions, including xenobiotic metabolism, eg, cytochrome P450 family 1 member 1A (Cyp1a1) (Beischlag et al., 2008) . Recently, AHR has been shown to interact with other transcription factors to drive cytokine production and developmental programing in the immune system (Apetoh et al., 2010; Quintana et al., 2008; Veldhoen et al., 2008) . In particular, the AHR can physically interact with the transcription factor NF-kB, leading to gene regulation at many inflammatory gene promoters (DiNatale et al., 2010; Vogel et al., 2013 Vogel et al., , 2014 .
Here we employ an ex vivo murine macrophage system to explore the cooperation between the AHR and inflammatory signaling to drive Ccl20 gene expression. We show that activation of AHR with ligands, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), or activation of NF-kB via toll-like receptor 4 (TLR4) agonist, lipopolysaccharide (LPS), induces Ccl20 gene expression. Combinatorial treatments with both stimuli synergize to drive Ccl20 gene expression in primary macrophages. These observations contribute to the complexity of chemokine gene expression, suggesting that the presence of AHR ligands may affect the recruitment of T cells and other CCR6 expressing cells to tumors or sites of infection.
MATERIALS AND METHODS
Reagents. TCDD was kindly provided by Dr Stephen Safe (Texas A&M University, College Station, Texas). Indolo [3,2b] Primary peritoneal macrophage isolation from mice. For the isolation of primary peritoneal macrophages, mice were IP injected with 3 ml of 3% thioglycolate media on day 1. After 72 h mice were euthanized through asphyxiation. Primary peritoneal macrophages were isolated by peritoneal lavage using ice-cold phosphate buffered saline (PBS). Cells were recovered by centrifugation and resuspended in macrophage cell culture medium (Zhang et al., 2008) .
Cell culture. Primary peritoneal macrophages were maintained at 37 C and 5% CO 2 in Dulbecco's modified eagle medium (Gibco, Carlsbad, California) supplemented with 10% fetal bovine serum (Hyclone Labs, Logan, Utah), 100 IU/ml penicillin and 100 mg/ml streptomycin, 2mM L-glutamine, and 1 mM sodium pyruvate (Sigma).
Primary keratinocyte isolation from mice. Keratinocytes from less than 3-day-old Ahr b , Ahr
À/À
, and Ahr þ/À mice were isolated and cultured in primary keratinocyte medium as described previously (Dlugosz et al., 1995) .
RNA extraction and quantitative RT-PCR. Upon treatments, total RNA was isolated from macrophages as previously described using Trizol (Invitrogen Carlsbad, California) (Murray et al., 2010b) . Total RNA was converted into cDNA using a HighCapacity cDNA Archive kit (Applied Biosystems, Foster City, California). Gene expression was measured using quantitative RT-PCR as previously described (Murray et al., 2010b) , utilizing the primers described in Supplementary Table S1 .
CCL20 ELISA. CCL20 ELISA was performed on macrophage culture supernatants. Harvested supernatants were briefly spun at 5000 rpm for 3 min to remove cellular debris. ELISA was performed as per the manufacturer's protocol (Cayman Chemicals).
Electromobility shift assay. Electrophoretic mobility shift assays (EMSA) were performed using in vitro-translated mouse AHR and ARNT proteins or nuclear extracts from peritoneal macrophages exposed to vehicle or TCDD as described previously (Flaveny et al., 2009; Singh et al., 1996) . Ccl20 oligonucleotides spanning the AHR binding site are described in Supplementary Table S2 .
Preparation of cytosolic and nuclear fractions. Cytosolic and nuclear fractions were prepared from primary peritoneal macrophages isolated from Ahr b and Ahr À/À mice as described previously (Lahoti et al., 2013) . Protein samples were resolved on 8% polyacrylamide gel and transferred onto polyvinylene difluoride membranes. Primary and secondary antibodies are described in Supplementary Table S3 .
Chromatin immunoprecipitation assays. Primary macrophages were isolated from C57BL6/J mice and plated in 150-mm cell culture plates. Macrophages were treated with 5 ng/ml lipopolysaccharide (LPS) for 45 min or 10nM TCDD for 30 min followed by 5 ng/ml LPS for 45 min. Each treatment was performed in triplicate. Following treatment, the medium was removed and cells were chemically cross-linked using 1% formaldehyde in warm PBS for 10 min at room temperature. Cross-linking was terminated by adding glycine to a final concentration of 0.125 M for 5 min at room temperature. Cells were washed twice with cold PBS and collected in harvest buffer (100 mM Tris-HCl, pH 8, 10 mM dithiothreitol). The cells were centrifuged at 2000 rpm for 5 min, washed with PBS, and resuspended in lysis buffer (1% lithium dodecyl sulfate, 50 mM EDTA, protease inhibitor cocktail, 50 mM Tris-HCl, pH 8). Chromatin was sheared with the Bioruptor water bath sonicator (Diagenode, Sparta, New Jersey) to an average size of 0.5-1 kb and centrifuged at 10 000 rpm for 10 min. The sheared chromatin was diluted to 50 mg/ml in dilution buffer (1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8) and 500 ml chromatin was incubated for 4 h at 4 C with 2 mg of the following antibodies:
rabbit anti-AhR (a kind gift from Dr Pollenz, University of South Florida), anti-HDAC1 (Santa Cruz Biotechnology, California), and rabbit IgG (Santa Cruz Biotechnology) as control. Immunoadsorbed complexes were captured on Protein G magnetic beads (New England BioLabs, Massachusetts) for 2 h at 4 C and washed 3 times with RIPA (1% Triton X-100, 1 mM EDTA, 0.5 mM EGTA, 0.1% Na-deoxycholate, 140 mM NaCl, 10 mM TrisHCl, pH 8) followed by one wash with TE8 (1 mM EDTA, 10 mM Tris-HCl, pH 8). DNA was eluted in 200 ml elution buffer (100 mM NaHCO 3 , 1% SDS) at 65 C overnight. Eluted DNA was purified using the chromatin immunoprecipitation assays (ChIP) DNA Clean & Concentrator kit (Zymo Research, California) and analyzed by quantitative real-time PCR.
RESULTS

Treatment With an AHR Agonist in Combination With LPS Synergistically Induces Ccl20 Gene Expression in Macrophages
A previous report suggested that expression of a constitutively active AHR in skin of transgenic mice induced Ccl20 expression. However, this study did not identify whether the AHR directly regulated Ccl20 gene expression (Tauchi et al., 2005) . Numerous reports suggest that Ccl20 gene expression can be significantly induced by microbial factors such as LPS, contributing to human pathologies such as sepsis (Crane-Godreau and Wira 2005; Scapini et al., 2002) . Stimulated macrophages have been shown to secrete CCL20 and contribute to the chemotaxis of inflammatory T cells to a given site (Li et al., 2013) . Therefore the role of AHR activation on Ccl20 expression in the absence or presence of LPS was examined utilizing an ex vivo mouse macrophage system. Our initial data suggested that activation of AHR in primary peritoneal macrophages by prototypical AHR ligand TCDD and/or gram-negative bacterial cell wall product LPS stimulated a dosedependent increase in Ccl20 mRNA expression (Figs. 1A and 1B) . This suggests that there are multiple mechanisms capable of inducing Ccl20 gene regulation. Furthermore, the addition of both TCDD and LPS in macrophages resulted in an 8-fold synergistic induction of Ccl20, indicating a complex interplay between activation of AHR and TLR pathways that was previously poorly described (Fig. 1B) . We also observed a time dependency in synergy as maximum induction of Ccl20 expression was identified at 4 h post TCDD and LPS coexposure ( Supplementary Fig. 1S ). The reason for the reduced level of synergism observed at 6 h is not known. In addition, macrophages coexposed to different AHR agonists, such as ICZ, combined with LPS, initiated a similar increase in Ccl20 expression (Fig. 1C) .
AHR/LPS-Mediated Synergistic Induction of Ccl20 Is a Direct Transcriptional Event
To further study the role of agonist-mediated AHR-ARNT activation on Ccl20 gene transcription, macrophages were preexposed to protein translation inhibitor cycloheximide (CHX; 10 lg/ml) for 1 h. In the absence of CHX, TCDD and LPS synergistically induced expression of Ccl20 (Fig. 1D ). Pre-exposure to CHX had no effect on the synergistic induction of Ccl20 mRNA mediated by TCDD and LPS cotreatment (Fig. 1D) . The failure of CHX to alter the TCDD/LPS synergistic effect on the induction of Ccl20 mRNA expression is consistent with the assertion that AHR-mediated induction of Ccl20 is a direct primary transcriptional event. It is important to note that the increased AHRmediated transcriptional activation of Cyp1a1 has been observed in the presence of CHX (Joiakim et al., 2004; Lusska et al., 1992; Ma and Baldwin, 2002) .
Synergistic Induction of Ccl20 Expression by AHR Activation Can Also Be Observed in IL1B-Stimulated Macrophages and in LPSTreated Primary Keratinocytes That Express AHR
Previous studies have shown that cells stimulated with IL1B can also induce Ccl20 gene expression (Lahoti et al., 2013; Shindo et al., 2014) . Thus, we investigated whether IL1B and TCDD cotreated macrophages could synergistically induce Ccl20 mRNA expression. Similar to the results obtained with LPS, cells exposed to IL1B lead to potentiation of TCDD-mediated expression of Ccl20 ( Fig. 2A) . Studies have shown that CCL20 plays a critical role in psoriasis and higher levels of CCL20 protein were observed in keratinocytes from psoriatic patients (Harper et al., 2009; Kennedy-Crispin et al., 2012) . We wanted to investigate whether the synergy in Ccl20 mRNA expression obtained in macrophages could also be observed in primary mouse keratinocytes. The data revealed a 5-fold induction of Ccl20 in primary keratinocytes from Ahr b mice exposed to LPS and TCDD compared with either agent alone (Fig. 2B) . These results also reveal that the observed synergy is AHR dependent, as keratinocytes from Ahr þ/À and Ahr À/À mice largely failed to respond. In addition, lack of AHR expression attenuated LPS-mediated induction of Ccl20, suggesting that AHR contributes to the induction of Ccl20 even in the absence of exogenous ligand.
LPS Mediates an Increase in AHR Protein Levels
Macrophages exposed to LPS resulted in a time-dependent increase in Ahr transcription, with a maximum level of induction obtained after 3 h of LPS exposure (Fig. 3A) . In addition, AHR protein levels were enhanced in a time-dependent manner (Fig. 3B) . Next, we wanted to test whether LPS-mediated upregulation in AHR protein levels influenced target gene expression. Thus, macrophages from Ahr b and Ahr À/À mice were treated with LPS for 24 h, followed by TCDD exposure for 3 h. The results established that the induction of both Cyp1a1 and Ccl20 mRNA expression by TCDD was dependent on AHR expression (Fig. 3C ). In addition, synergistic induction of Ccl20 was observed in macrophages from Ahr b mice when exposed to LAHOTI ET AL. | 231 LPS for 24 h followed by TCDD exposure for 8 h. Interestingly, this result suggests that AHR expression is required for optimal LPS-mediated induction of Ccl20.
The Synergistic Induction of Ccl20 Mediated by AHR Agonist and LPS Is AHR Dependent in Primary Macrophages
To further delineate the level of AHR dependency on Ccl20 gene expression, macrophages were isolated from Ahr b and Ahr À/À mice and exposed to TCDD and LPS using a short-term treatment regimen. Results indicated that Cyp1a1 expression was almost absent from Ahr À/À macrophages (Fig. 4A) . Furthermore, Western blot analysis demonstrated the absence of AHR expression in macrophages from Ahr À/À mice, in contrast to macrophages from Ahr b mice (Fig. 4B ). This lack of AHR in macrophages resulted in a complete loss of AHR agonistmediated induction of Ccl20 transcription (Fig. 4C) . Furthermore, despite being equally sensitive to LPS-mediated induction in Ahr b , Ahr À/À macrophages proved to be refractory to combinatorial agonist/LPS-mediated synergistic induction of Ccl20. To determine the effect of AHR dependency on CCL20 protein by 5 ng/ml LPS for 4 h. D, Macrophages were pretreated with TCDD for 1 h followed by 5 ng/ml LPS for 4 h. Where indicated, CHX was added 10 min prior to the addition of TCDD. Data represent mean mRNA levels normalized to Actb mRNA expression 6 SEM (n ¼ 3/treatment group; *P < .05, **P < .01, ***P < .001). , and Ahr À/À newborn mice were treated with TCDD for 1 h, followed by 5 ng/ml LPS for 4 h. Data represent mean mRNA levels normalized to Actb mRNA expression 6 SEM (n ¼ 3/treatment group; *P < .05, **P < .01, ***P < .001).
FIG. 2. IL1B and TCDD synergize to induce
levels, macrophages from Ahr b and Ahr À/À mice were exposed to TCDD and LPS for 8 h. An ELISA was performed on cell culture supernatant; results obtained were similar to the data observed at the mRNA level, with a 4-fold induction of CCL20 protein levels upon combinatorial treatment compared with treatment with TCDD or LPS alone (Fig. 4D) . Overall, the results suggest that synergistic induction of Ccl20 by exposure to TCDD and LPS is dependent on AHR expression and activation.
AHR Agonist-Mediated Induction of Ccl20 Is Dependent on Nuclear Translocation of the AHR Whether AHR activation of Ccl20 transcription requires the liganded AHR to reside in the nucleus was examined utilizing macrophages isolated from Ahr nls/nls mice. These mice carry a mutation in the composite NLS/DNA binding domain sequence; thus the mutated AHR fails to both translocate into the nucleus and bind to DREs (Bunger et al., 2008 (Fig. 5 ). Although mouse genotype had no effect on LPSmediated induction of Ccl20, combinatorial treatment of macrophages with LPS and an AHR agonist resulted in synergistic induction of Ccl20 in Ahr d macrophages. In contrast, only a modest induction of Ccl20 was observed in Ahr nls/nls macrophages, consistent with the requirement for nuclear localization to induce Ccl20 transcription.
FIG. 3.
After long-term exposure to LPS in macrophages TCDD treatment still mediated synergistic induction of Ccl20 in an AHR-dependent manner. Primary macrophages from Ahr b and Ahr À/À mice were isolated via peritoneal lavage. A, Relative levels of Ahr mRNA in cultured macrophages after LPS treatment for 3 or 6 h. B, Timedependent increase in AHR protein expression in macrophages after LPS treatment for the indicated times. C, Primary macrophages derived from Ahr b mice were pretreated with LPS for 24 h, followed by TCDD treatment for 3 h; Cyp1a1 and Ccl20 relative mRNAs were assessed. Data represent mean mRNA levels normalized to Actb mRNA expression 6 SEM (n ¼ 3/treatment group; *P < .05, **P < .01, ***P < .001).
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AHR Activation Does Not Influence LPS-Mediated NF-kB Translocation
Macrophages isolated from Ahr b and Ahr À/À mice and maintained in cell culture were treated with LPS or LPS-TCDD for 1 h and p65 was localized using indirect immunofluorescence microscopy ( Supplementary Fig. 2S ). No difference in p65 translocation into the nucleus was observed whether the AHR is expressed or upon ligand activation.
Agonist-Mediated AHR Activation Promotes Binding of the AHR-ARNT Protein Complex to DREs Present on Ccl20
Promoter AHR agonist-mediated gene activation is primarily associated with binding of heterodimerized AHR-ARNT protein complex to the DREs present on the gene promoters. The induction of Ccl20 gene transcription by TCDD or ICZ in an AHR-dependent fashion suggests that the agonists could invoke binding to DREs present on the Ccl20 promoter (Fig. 1C) . To determine whether the same mechanism of gene activation is utilized here, we examined the 5 kb upstream promoter of the Ccl20 gene relative to the transcription start site. Four putative DREs along with the NF-kB binding site on the Ccl20 promoter were identified by in silico analysis (Fig. 6A) . To examine the functional significance of the identified DREs, gel shift analysis was performed.
In vitro-translated mouse AHR and ARNT proteins were exposed to TCDD, leading to the formation of AHR-ARNT complexes. These were then mixed with radiolabeled D, Macrophages were pretreated with 10 nM TCDD for 1 h followed by 5 ng/ml LPS or vehicle for 8 h. ELISA was performed on supernatants collected from Ahr b and Ahr À/À macrophages. Data represent mean mRNA levels 6 SEM (n ¼ 3/treatment group; *P < .05, **P < .01, ***P < .001).
FIG. 5.
Synergistic induction of Ccl20 levels requires AHR nuclear translocation. Primary macrophages were isolated from Ahr d and Ahr nls mice via peritoneal lavage.
Cyp1a1 and Ccl20 mRNA levels were assessed 4 h after the various indicated treatments. Data represent mean mRNA levels 6 SEM (n ¼ 3/treatment group; **P < .01, ***P < .001). The term "ns" means no significant difference between data bars under the line. LAHOTI ET AL. | 235 oligonucleotides corresponding to 3 different DRE-containing regions of the Ccl20 promoter. Gel shift analysis suggests that TCDD-mediated AHR-ARNT protein complexes can bind to the DREs present on the Ccl20 promoter, with maximum binding observed at the 3.1 kb putative DRE site (Fig. 6B ). Other AHR agonists were tested and ICZ, tryptanthrin, and indoxyl sulfate were all capable of inducing AHR binding to the 3.1 kb oligonucleotide (Fig. 6C) , suggesting that many AHR agonists can promote binding of AHR-ARNT to a DRE present on the Ccl20 promoter. To further study these events in macrophages from Ahr b mice, we exposed the macrophage cultures to TCDD and nuclear proteins were isolated. The isolated proteins were incubated with 32 P-radiolabeled sequences spanning DREs at 0.1, 3.1, and 3.2 kb. The data suggest that nuclear protein extracts of primary peritoneal macrophages from Ahr b mice exposed to TCDD could promote DRE binding of the AHR-ARNT protein complex (Fig. 6D ). The addition of nonradiolabeled DREs blocked binding to the radiolabeled oligonucleotide. In addition, AHR antibody addition induced an AHR-protein supershift of each oligonucleotide AHR complex. Overall, the data demonstrate the ability of AHR agonists to induce AHR-ARNT protein complex formation, which then binds DREs present in the Ccl20 promoter. Furthermore, the DRE at 3.1 kb is particularly efficient at binding the liganded AHR-ARNT complex.
LPS Promotes AHR Recruitment to the Ccl20 Promoter in Macrophages
ChIP assays were performed to further examine the mechanism of AHR-mediated synergistic induction of Ccl20 transcription. Treatment of macrophages with LPS leads to an increase in AHR occupancy on both the Cyp1a1 and Ccl20 promoters (Fig. 7) . In contrast, LPS treatment led to a significant decrease in HDAC1 presence on the Cyp1a1 and Ccl20 promoters. Surprisingly, combinatorial treatment with TCDD and LPS actually yielded an apparent lower level of AHR occupancy. The reason for this result has not been elucidated. Nevertheless, these results indicate that the AHR can be recruited to the Ccl20 promoter and is associated with synergistic Ccl20 induction.
Ccl20 Expression Is Repressed in the Colon of Ahr 2/2 Mice
The data in Figure 3C would suggest that the AHR expression might play a role in the constitutive and LPS-inducible expression of Ccl20, to examine this in vivo in a tissue that is exposed to bacterial inflammatory signaling molecules. The level of expression of Ccl20 was examined in the colon of Ahr À/À and Ahr þ/À mice and there was a dramatic decrease in Ccl20 mRNA levels in Ah À/À mice (Fig. 8) .
DISCUSSION
Expression of the AHR plays an important role in both the innate and adaptive immune status of the gastrointestinal tract (Quintana and Sherr, 2013; Stange and Veldhoen, 2013) . In particular, the AHR participates in the postnatal expansion of intestinal innate lymphoid cells and the differentiation of T cells (Kiss et al., 2011; Quintana et al., 2008) . Intestinal exposure studies have revealed that Ahr À/À mice are highly susceptible to either dextran sodium sulfate or Citrobacter rodentium challenge (Furumatsu et al., 2011) . These studies clearly indicate a critical role for AHR in intestinal immune homeostasis. In a normal healthy gut the resident macrophage population exhibits a noninflammatory phenotype characterized by low levels of TLR2 and TLR4, CD14, CD80 and CD89 (Smith et al., 2001) . However, during a bacterial challenge a subset of macrophages, characterized by the expression of CX3CR1, expands into inflammatory macrophages that respond to the infection (Bain et al., 2013) . These cells in turn produce chemokines to attract other immune cells to the infection site. One key chemokine, CCL20, is expressed in cells of epithelial origin, macrophages and Th17 cells (Li et al. 2013 ). CCL20 expression is induced by inflammatory mediators, such as LPS and other bacterial components, and is the primary ligand for the chemokine receptor CCR6 (Hausmann et al., 2012; Ito et al., 2011) . The recruitment of CCR6þ cells (eg, macrophages, dendritic cells, and T cells) to the site of injury is critical for an effective response to bacterial invasion. Our results suggest that the expression of CCL20 in the colon is partial dependent of AHR, supporting the notion that the presence of AHR agonists would likely enhance the overall response to an intestinal challenge. However, in the absence of a strong agonist, the AHR presumably in the cell cytoplasm can inhibit inflammatory signaling, perhaps leading to enhanced resolution of inflammation. Support for this concept can be found in several studies in macrophages, where the absence of AHR expression leads to an enhanced inflammatory phenotype (Beamer et al., 2012; Kimura et al., 2009; Masuda et al., 2011; Sekine et al., 2009) . In addition, the use of selective Ah receptor modulators that exhibit essentially no DRE-mediated activity elicit a potent anti-inflammatory activity (Murray et al., 2010a) . After long-term exposure to inflammatory mediators, we have shown that AHR protein levels are increased 2-fold in primary macrophages. Results are similar to the increased levels of AHR observed in peritoneal exudate cells from LPS-treated mice (Bessede et al., 2014) . Recent studies have demonstrated that there are several functional NF-kB elements in the AHR promoter (Vogel et al., 2014) . These observations are consistent with the AHR either mediating a sustained level of inflammatory signaling or a feedback loop that leads to antiinflammatory activity dependent on whether AHR agonists are present.
The Il6 promoter has been extensively characterized in terms of the ability of NF-kB and AHR to synergistically induce transcription (DiNatale et al., 2010) . A cluster of putative DREs is located $3 kb upstream from the transcriptional start site of Il6; occupation of this site by AHR/ARNT results in the dismissal of HDAC1 and subsequent acetylation of NF-kB, leading to dramatically enhanced transcription. However, this cluster of DREs in the Il6 promoter, when considered in the context of a reporter vector with a heterologous promoter, was only modestly capable of driving transcription in a transient cell transfection experiment. Interestingly, at 3.1 kb upstream from the transcriptional start site of the Ccl20 promoter there are potent tandem DREs that are highly efficient with regard to AHR heterodimer binding in the context of gel shift analysis. As in the case of Il6, these DREs failed to mediate transcription in the context of a reporter vector in the presence of an AHR agonist (data not shown). After LPS exposure in primary macrophages, the AHR is clearly recruited and HDAC1 is dismissed from the Ccl20 promoter. This was an unexpected result, as generally only AHR ligand treatment causes a significant increase in promoter occupancy. Interestingly, this result is similar to the ability of calcium-induced signaling in primary keratinocytes to lead to retention of the AHR in the nucleus (van den Bogaard et al., 2015) . Indeed, LPS can induce calcium signaling in macrophages, thus the possible connection between calcium signaling and AHR activation in the macrophages should be investigated (Ren et al., 2014) . It was also intriguing to find that the addition of an AHR ligand apparently decreased the level of occupancy when in combination with LPS-the reason for this result is not known. However, the high level of transcriptional activity that occurs with combinatorial treatment may result in epitope access issues in the ChIP assays. Nevertheless, the presence of the AHR on the promoter appears to participate in the synergistic activation of Ccl20 transcription. A pictorial scheme depicting the proposed mechanism of combinatorial activity at the Ccl20 promoter is shown in Supplementary Figure 3S . The fact that Il6 and Ccl20 exhibit similar modes of regulation prompts the question of how many cytokine/chemokine genes are in part regulated by the AHR.
Activation and heterodimerization of the AHR with ARNT during innate inflammatory signaling likely evolved as a means to respond to the presence of ligands produced either through dietary consumption, endogenous production, or tryptophan metabolism by flora (Fukumoto et al., 2014; Magiatis et al., 2013) . Interestingly, the human AHR exhibits dramatically enhanced activation potential for indolic derivatives, such as indirubin, relative to the mouse AHR (Flaveny et al., 2009 ). In the case of a yeast skin infection in humans, AHR ligands (eg, indirubin, indolo[3,2b] carbazole, and malassezin) are produced that lead to the host inflammatory and barrier responses. This could explain why the AHR plays a role in the differentiation of T cells as a means to enhance the host response to infection. In addition, the enhanced production of CCL20 mediated by AHR activation could play an important role in the recruitment of T cells within the gastrointestinal tract. For example, in the presence of inflammation mediated by invasive bacteria, the production FIG. 7. LPS mediates AHR occupancy onto the Ccl20 promoter and HDAC1 dismissal. ChIP analyses were performed using primary macrophage cultures treated with TCDD or vehicle for 60 min followed by LPS or vehicle treatment for 30 min. ChIP assays were performed using either anti-AHR or anti-HDAC1 immunoprecipitations and qPCR was performed using primers localized near the 0.5 kb (A) and 3.0 kb (B) region upstream from the transcriptional start site of Ccl20, as well as primers to the proximal promoter region of the Cyp1a1 promoter (C).
FIG. 8. Ccl20 expression is attenuated in the colon of Ahr
À/À mice. The level of Ccl20 expression in the colon of Ahr À/À and Ahr þ/À was assessed using qRT-PCR.
Data represent mean mRNA levels normalized to L-13a mRNA expression 6 SEM (n ¼ 3/treatment group; ***P < .001).
LAHOTI ET AL. | 237 of AHR ligands would further increase chemokine expression and thus the recruitment of immune cells to the site of infection. Furthermore, the CCL20-CCR6 axis may also play a critical role in intestinal tumorigenesis, where AHR activation would likely enhance the tumorigenesis process through the generation of an inflammatory environment (Nandi et al., 2014) . In this environment, IDO1 is likely up-regulated, which could lead to the production of AHR ligands to further enhance response to a toxic insult. The AHR has also been shown to contribute to inflammatory signaling in other chronic diseases, such as rheumatoid arthritis (Kobayashi et al., 2008) . Synoviocytes isolated from rheumatoid arthritis patients during joint replacement exhibit significant constitutive Ccl20 expression, which is in part mediated by AHR activity (Lahoti et al., 2013) . In conclusion, these studies yield further insight into the mechanisms that mediate participation of the AHR in inflammation.
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